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Endothelial dysfunction is believed to predispose thevascular smooth muscle to increased tone, decreased
vasomotion, altered reactivity, changes in structure and
geometry, enhanced platelet aggregation, and eventual
atherosclerosis or graft failure. Elucidating the mecha-
nisms of endothelial dysfunction in bypass conduits has
implications in terms of vessel spasm, graft patency,
and the outcome of coronary artery bypass graft
(CABG) operations. A strong body of evidence sup-
ports the notion that nitric oxide (NO) is one of the most
important antiatherosclerotic agents produced by the
endothelium.1 Indeed, the resilience of the internal tho-
racic artery and its resistance to atherosclerosis has
been attributed in part to the potent endothelial NO sys-
tem in these vessels.2 In contrast, the increased rates of
atheroslcerotic changes in saphenous veins has been
Objectives: Diminished production of nitric oxide has been linked to saphe-
nous vein endothelial dysfunction. Tetrahydrobiopterin is an obligate cofac-
tor for the oxidation of L-arginine by nitric oxide synthase in the production
of nitric oxide by endothelial cells. The objective of the present study was to
examine whether the exogenous addition of tetrahydrobiopterin improves
endothelial function in saphenous veins from patients undergoing coronary
artery bypass graft operations.
Methods: Vascular segments of saphenous veins were obtained from 17
patients undergoing elective coronary artery bypass grafting, and in vitro
endothelium-dependent and endothelium-independent responses to acetyl-
choline and sodium nitroprusside were assessed. Isometric dose-response
curves were constructed in precontracted rings in the presence and absence
of tetrahydrobiopterin (0.1 mmol/L) with the use of the organ bath appara-
tus. The percentages of maximum relaxation and sensitivity were compared
between interventions.
Results: Acetylcholine caused dose-dependent endothelium-mediated relax-
ation in saphenous veins. In the presence of tetrahydrobiopterin, acetyl-
choline-induced relaxation was significantly augmented (percentage maxi-
mum relaxation, 16.8% ± 2.9% vs control 7.5% ± 1.8%; P = .003) without
an effect on agonist sensitivity. These effects were endothelium-specific
because endothelium-independent responses to sodium nitroprusside were
preserved.
Conclusions: These data uncover beneficial effects of acute tetrahydro-
biopterin addition on endothelial function in human vessels. Because
endothelial dysfunction has been implicated in the development of graft fail-
ure, studies aimed at chronic delivery of tetrahydrobiopterin would be useful
in determining the contribution of this cofactor toward saphenous vein ath-
erosclerosis.  (J Thorac Cardiovasc Surg 2000;120:668-71)
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linked to diminished production of endothelium-
derived NO in these conduits.2 Hence, targeting the
pathways of NO synthesis and production in the
endothelium of venous grafts has important ramifica-
tions. The results of one such approach with tetrahy-
drobiopterin (BH4) are described in this article. BH4 is
an absolute cofactor for endothelial NO synthase
(NOS).3 Because low levels of BH4 may lead to
endothelial dysfunction through decreasing NO pro-
duction or enhancing its breakdown, the present study
was aimed at examining the effects of this cofactor on
in vitro endothelium-dependent and endothelium-inde-
pendent vascular responses in human saphenous veins.
Methods
We obtained saphenous vein segments (2-3 cm) from 17
patients undergoing CABG operations after obtaining written
informed consent. The vessels were cut into rings (~5 mm)
and suspended in an isolated tissue bath (under 4g tension)
containing oxygenated Krebs buffer (37°C) to record isomet-
ric dose-response curves. After 60 minutes of equilibration,
the vessels were stimulated according to the following proto-
col: (1) cumulative dose-response curves to phenylephrine
(10–8 to 10–5 mol/L); (2) cumulative dose-response curves to
acetylcholine in rings precontracted with the effective dose
causing 75% of the maximum contraction to this agonist
(ED75) of phenylephrine; (3) cumulative dose-response
curves to acetylcholine in the presence and absence of BH4
(0.1 mmol/L for 20 minutes); and (4) cumulative dose-
response curves to sodium nitroprusside in the presence and
absence of BH4. After the initial dose-response curve to
phenylephrine (step 1), the dose that evoked 75% of the max-
imum obtained tension response was used to preconstrict the
vascular segments for the relaxation studies (steps 2-4). The
percentages of maximum relaxation (%Emax) and agonist
sensitivity (pEC50) were compared between interventions.
The %Emax values were calculated manually from each
dose-response curve tracing, and results were averaged and
quoted as means ± SE. pEC50 values are an index of agonist
sensitivity and represent –logEC50. Nonlinear analysis of the
individual dose-response curves was performed, and the
obtained pEC50 values were averaged and presented as means
± SE. %Emax values were compared by means of a 2-tailed
t test. The dose-response curve was compared by means of
repeated-measures analysis of variance followed by a
Newman-Keuls test for post hoc comparisons.
Results
Patient characteristics.  Table I depicts the character-
istics and risk factor profiles of the patient population.
The distribution of coronary artery disease risk factors
in this study population was comparable with that
found in other studies with similar methods.4
Vascular relaxation. In precontracted arteries
acetylcholine caused dose-dependent endothelium-
mediated relaxation (%Emax, 7.5% ± 1.8%; pEC50,
6.52% ± 0.06). This effect was endothelium specific
Table I.  Demographic characteristics
No. of patients 17*
Risk factors
Age (y) 59 ± 4
Smoking, n (%) 8 (47)
Hypertension, n (%) 7 (42)
Diabetes, n (%) 4 (23)
Obesity (BMI ≥27), n (%) 8 (48)
Family history, n (%) 10 (59)
Hypercholesterolemia, n (%) 11 (65)
Total cholesterol (mmol/L) 6.3 ± 0.5
Drugs
ACE inhibitors, n (%) 6 (35)
Calcium antagonists, n (%) 7 (41)
Antioxidant vitamins, vitamin B6, folate, B12; n (%) 3 (18)
β-Blockers, n (%) 10 (58)
Nitroglycerin, n (%) 10 (58)
BMI, Body mass index; ACE, angiotensin-converting enzyme.
*The group comprised 11 men and 6 women.
Fig 1. Endothelium-dependent vascular relaxation to acetyl-
choline (ACh) in saphenous veins in the absence (control) and
presence of 0.1 mmol/L of tetrahydrobiopterin (20 minutes).
Data are represented as means ± SE. Vascular relaxation is
expressed as the percentage of maximum relaxation in rings
precontracted with the ED75 of phenylephrine. Saphenous
vein segments were collected from 17 patients undergoing
elective CABG operations and cut into two rings for determi-
nation of isometric dose-response curves to acetylcholine in
the absence and presence of BH4. Because of limitations in
vessel length, in 5 of 17 patients, only one ring could be pre-
pared. In the presence of BH4, endothelium-dependent
responses to acetylcholine were significantly augmented.
Weak endothelium-dependent relaxation is typical of saphe-
nous veins.
because it was abolished in vessels denuded of the
endothelium (not shown). The effects of BH4 on acetyl-
choline- and sodium nitroprusside–mediated relaxation
are depicted in Figs 1 and 2. In the presence of BH4,
endothelium-mediated relaxation to acetylcholine was
improved significantly (%Emax, 16.8% ± 2.9% vs con-
trol; P = .003) without an effect on agonist sensitivity
(pEC50, 6.57 ± 0.06 vs control; P = .2). The beneficial
effects were endothelium specific because the respons-
es to the endothelium-independent vasodilator (sodium
nitroprusside) were preserved (Fig 2).
Discussion
These data uncover the ability of BH4 to augment
endothelium-mediated vasodilation in saphenous veins
from patients undergoing CABG operations. In the
presence of BH4, acetylcholine responses improved
approximately 2-fold, an effect specific for the
endothelium. Because endothelial dysfunction and
diminished NO production are key determinants of
atherogenicity,1 this observation may have theoretic
implications for vein graft atherosclerosis.
The effects of BH4 on endothelial function are an
area of much current interest in the field of cardiovas-
cular and cerebrovascular research.5,6 In the landmark
article by Higman and colleagues,6 exogenous BH4
addition was demonstrated to improve endothelial
function in saphenous veins recovered from smokers
without other endothelial or coronary risk factors. Data
from the present study serve to confirm, complement,
and extend the observations made by Higman and col-
leagues6 by demonstrating the beneficial effects of this
cofactor on endothelial function in the face of multiple
risk factors. Because patients undergoing CABG oper-
ations often have a clustering of endothelial risks, these
observations closely mimic those of the cohort of
patients undergoing coronary revascularization.
However, the contribution of individual risk factors
toward endothelial dysfunction and the observed
effects of BH4 cannot be made. All major risk factors
for atherosclerotic vascular disease have been associat-
ed with impaired NO activity.7 Hence it is plausible
that the beneficial effects of BH4 may extend non-
specifically to any process that dampens endothelial
function through affecting NO production, release, or
availability.
The primary role of BH4 appears to be as an obligate
cofactor for the enzyme NOS III in the endothelium.3,7
NOS III consists of a flavin-containing reductase
domain and a heme-containing oxidase domain.
Reduced nicotinamide adenine dinucleotide phosphate
reduces the flavin component of the reductase domain;
however, electron transfer to heme does not occur until
calcium-calmodulin is present. In the presence of calci-
um-calmodulin, an electron transfer from reduced
nicotinamide adenine dinucleotide phosphate to heme
occurs, and with L-arginine present, electrons can flow
to the heme moiety to reduce oxygen, which in turn is
used to oxidize L-arginine to NO (5 electron trans-
fer).3,7 BH4 is an essential cofactor for the proper flow
of electrons to oxidize L-arginine, and hence endothe-
lial NO production is highly dependent on the presence
of adequate amounts of this agent.3 BH4 has also been
suggested to induce a change in the NOS confirmation
to the high-affinity state (allosterism) and increase the
affinity of NOS for L-arginine. Therefore the addition
of BH4 may improve saphenous vein endothelial func-
tion through enhancing or restoring the ability of NOS
III to produce NO. On the other hand, low levels of
BH4 shift the balance between NO and oxygen-derived
free radicals, such that oxygen becomes an electron
acceptor (vs L-arginine) and produces superoxide
anions and hydrogen peroxide, potent inducers of
endothelial dysfunction. Although BH4 substitution
may correct this imbalance in saphenous veins, this
mechanism seems unlikely given the presence of ascor-
bic acid in the buffer. Finally, recent data suggest that
BH4 synthesis is associated with parallel stimulation of
superoxide dismutase in the vascular endothelium.3
Thus, BH4 may enhance NO production-stabilization
and improve endothelial function through a direct
antioxidant effect.
In human saphenous veins the production of con-
stricting prostanoids and thromboxane A2 have been
linked to endothelial dysfunction.8 In addition, data
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Fig 2.  Saphenous vein relaxation to the endothelium-inde-
pendent vasodilator sodium nitroprusside (SNP) in the pres-
ence and absence of BH4. Sodium nitroprusside–induced vas-
cular relaxation was not augmented by BH4, suggesting that
the action of this cofactor was specific for the endothelium.
and pathologic assessment of saphenous veins is need-
ed to specifically answer this question.
In summary, this study demonstrates that pharmaco-
logic modulation of NOS by exogenous BH4 addition
exerts beneficial effects on endothelial function in
human saphenous veins used for CABG operations.
Understanding and improving endothelial function is a
key factor in promoting saphenous vein thromboresis-
tance.
R E F E R E N C E S
1. Luscher TF, Noll G. The pathogenesis of cardiovascular disease:
role of the endothelium as target and mediator. Atherosclerosis
1995;188:S81-90.
2. Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P,
von Segesser L, et al. Differences between endothelium-depen-
dent relaxation in arterial and venous coronary bypass grafts. N
Engl J Med 1988;319:462-7.
3. Cosentino F, Lusher TF. Tetrahydrobiopterin and endothelial
function. Cardiovasc Res 1999;43:274-8.
4. Huraux C, Makita T, Kurz S, Yamaguchi K, Szlam F, Tarpey
MM, et al. Superoxide production, risk factors, and endothelium-
dependent relaxations in human internal mammary arteries.
Circulation 1999;99:53-9.
5. Tsutsui M, Milstien S, Katusic ZS. Effect of tetrahydrobiopterin
on endothelial function in canine middle cerebral arteries. Circ
Res 1996;79:336-42.
6. Higman DJ, Strachan AMJ, Buttery L, Hicks RCJ, Springall DR,
Greenhalgh RM, et al. Smoking impairs the activity of endothe-
lial nitric oxide synthase in saphenous vein. Arterioscler Thromb
Vasc Biol 1996;16:546-52.
7. Cosentino F, Luscher TF. Tetrahydrobiopterin and endothelial
function. Eur Heart J 1998;19(Suppl G):G3-8.
8. Yang Z, von Segesser L, Bauer E, Stulz P, Turina M, Lusher TF.
Different activation of endothelial L-arginine and cyclooxygenase
pathway in human internal mammary artery and saphenous vein.
Circ Res 1991;68:52-60.
9. Verma S, Lovren F, Mather KJ, Maitland A, Kieser T, McNeill
JH, et al. Novel endothelial protective effects of bosentan in inter-
nal mammary arteries (IMA) and saphenous veins (SV) from
patients undergoing bypass surgery [abstract]. Circulation
1999;100(Suppl):I-830.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 120, Number 4
Verma et al 671
from our laboratory suggest a role of endothelin-1 as a
potent modulator of endothelial function in human
saphenous veins.9 Whether these contracting factors are
primarily increased in saphenous veins or become
important as a result of diminished NO production
remains unknown. Whatever the exact mechanism, it is
apparent that restoring or augmenting NO production
may serve to counteract the actions of these vasocon-
strictors and improve endothelial function.
The increased rates of saphenous vein graft athero-
sclerosis (vs the internal thoracic artery) are related, at
least in part, to the poor production and release of
endothelium-derived NO.2 The weak responses to
acetylcholine in our study are consistent with those of
previously published reports. The current literature,
including this study, raises an important and central
question regarding saphenous vein endothelial function
per se. Why is endothelium-dependent vasomotion so
severely depressed in these vessels? Does this relate to
significant endothelial damage during harvesting and
distention? Is it related to decreased activity of the
endothelial NO system or are endothelium-derived
vasoconstrictors the culprit? Although pharmacologic
modulation (with BH4, indomethacin [INN: in-
dometacin], thromboxane, and endothelin antagonists)
improves saphenous vein endothelial function, it is
important to realize that the percentage of maximum
dilation to acetylcholine remains poor in the 20% to
30% range. Clearly, understanding and probing other
mechanisms of saphenous vein endothelial dysfunction
is needed to shed light on this issue.
Endothelial dysfunction is believed to predispose to
graft atherosclerosis and failure; hence, it is tempting to
speculate that long-term administration of BH4 may
serve as a useful tool in impeding this process. Results
from the present study depict an acute and single-dose
experiment that provides very limited information
about graft atherosclerosis. Devising a means of long-
term delivery of BH4 in conjunction with morphologic
